Thus, the development of CHD without cardiomyopathy is accompanied by an increased mobilization of EPCs from the bone marrow in response to atherogenesis under the action of excess SDF-1 in the blood, which are actively recruited to the heart by VEGF-A and PDGF. This evidence concerns the gene CXCL12 and cardiomyopathy.